Analysts have been eager to weigh in on the Healthcare sector with new ratings on Perrigo Company (PRGO), Cantel Medical (CMD) and Amgen (AMGN).
Perrigo Company (PRGO)
In a report released today, Elliot Wilbur from Raymond James maintained a Hold rating on Perrigo Company. The company’s shares closed last Thursday at $48.38.
According to TipRanks.com, Wilbur is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -3.4% and a 40.9% success rate. Wilbur covers the Healthcare sector, focusing on stocks such as Teva Pharmaceutical Industries, Sol-Gel Technologies, and ANI Pharmaceuticals.
Perrigo Company has an analyst consensus of Moderate Buy, with a price target consensus of $61.00.
See today’s analyst top recommended stocks >>
Cantel Medical (CMD)
In a report released today, Lawrence Keusch from Raymond James maintained a Hold rating on Cantel Medical. The company’s shares closed last Thursday at $47.04.
According to TipRanks.com, Keusch is a 4-star analyst with an average return of 4.9% and a 56.9% success rate. Keusch covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Baxter International, and Intuitive Surgical.
Cantel Medical has an analyst consensus of Hold, with a price target consensus of $58.00.
Amgen (AMGN)
In a report released today, Dane Leone from Raymond James maintained a Buy rating on Amgen. The company’s shares closed last Thursday at $248.08.
According to TipRanks.com, Leone is a 5-star analyst with an average return of 14.0% and a 64.8% success rate. Leone covers the Healthcare sector, focusing on stocks such as Adverum Biotechnologies, Ayala Pharmaceuticals, and Voyager Therapeutics.
Currently, the analyst consensus on Amgen is a Moderate Buy with an average price target of $266.14.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
